GSA Capital Partners LLP decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 67.8% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 2,201 shares of the healthcare conglomerate’s stock after selling 4,638 shares during the period. GSA Capital Partners LLP’s holdings in UnitedHealth Group were worth $760,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in UNH. Wealthcare Advisory Partners LLC increased its position in UnitedHealth Group by 5.0% during the 3rd quarter. Wealthcare Advisory Partners LLC now owns 8,963 shares of the healthcare conglomerate’s stock valued at $3,095,000 after purchasing an additional 428 shares during the period. Bedel Financial Consulting Inc. increased its position in shares of UnitedHealth Group by 6.3% during the third quarter. Bedel Financial Consulting Inc. now owns 1,139 shares of the healthcare conglomerate’s stock worth $393,000 after buying an additional 67 shares during the period. Rothschild Investment LLC lifted its holdings in UnitedHealth Group by 2.7% in the third quarter. Rothschild Investment LLC now owns 11,169 shares of the healthcare conglomerate’s stock valued at $3,857,000 after buying an additional 291 shares during the period. Schwarz Dygos Wheeler Investment Advisors LLC grew its holdings in UnitedHealth Group by 5.1% during the 3rd quarter. Schwarz Dygos Wheeler Investment Advisors LLC now owns 13,983 shares of the healthcare conglomerate’s stock worth $4,829,000 after acquiring an additional 684 shares during the period. Finally, Mondrian Investment Partners LTD acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $105,908,000. Institutional investors own 87.86% of the company’s stock.
Analyst Ratings Changes
Several brokerages have issued reports on UNH. Evercore raised UnitedHealth Group to a “strong-buy” rating in a research note on Tuesday, January 6th. Deutsche Bank Aktiengesellschaft lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 target price on the stock. in a research note on Wednesday, October 29th. Piper Sandler reiterated an “overweight” rating on shares of UnitedHealth Group in a report on Tuesday, January 27th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of UnitedHealth Group in a research report on Wednesday, January 21st. Finally, Truist Financial cut their price target on UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, February 2nd. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $372.13.
UnitedHealth Group Stock Performance
Shares of UNH opened at $290.11 on Friday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $606.36. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.82 and a current ratio of 0.79. The stock has a 50 day moving average price of $316.85 and a two-hundred day moving average price of $324.74. The firm has a market capitalization of $262.79 billion, a P/E ratio of 21.99, a P/E/G ratio of 1.33 and a beta of 0.41.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business had revenue of $113.22 billion during the quarter, compared to the consensus estimate of $113.38 billion. During the same quarter in the prior year, the company posted $6.81 earnings per share. UnitedHealth Group’s revenue was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Company Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Further Reading
- Five stocks we like better than UnitedHealth Group
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Gold $5,000: The 2026 Gold & Silver Summit is LIVE March 4
- How a Family Trust May Be Able To Help Preserve Your Wealth
- This makes me furious
- Elon Musk: This Could Turn $100 into $100,000
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
